Recombinant Proteins From Plants: Methods and Protocols
Altogether, the biochemical, technical and economic limitations on existing proka- otic and eukaryotic expression systems and the growing clinical demand for complex therapeutic proteins have created substantial interest in developing new expression systems for the production of therapeutic proteins. To that end, plants have emerged in the past decade as a suitable alternative to the current production systems, and today their potential for production of high quality, much safer and biologically active complex recombinant pharmaceutical proteins is largely documented. The chapters in this volume, contributed by leaders in the field, sum up the state— the-art methods for using a variety of different plants as expression hosts for phar- ceutical proteins. Several production platforms are presented, ranging from seed- and leaf-based production in stable transgenic plant lines, to plant cell bioreactors, to viral or Agrobacterium-mediated transient expr ession systems. Currently, antibodies and their derived fragments represent the largest and most important group of biote- nological products in clinical trials. This explains why the potential of most prod- tion platforms is illustrated here principally for antibodies or antibody fragments with acknowledged potential for immunotherapy in humans. In addition, a comparison of different plant expression systems is presented using aprotinin, a commercial phar- ceutical protein, as a test system. Although multiple books and monographs have been recently published on mol- ular pharming, there is a noticeable dearth of bench step-by-step prools that can be used quickly and easily by beginners entering this new field.
1101498612
Recombinant Proteins From Plants: Methods and Protocols
Altogether, the biochemical, technical and economic limitations on existing proka- otic and eukaryotic expression systems and the growing clinical demand for complex therapeutic proteins have created substantial interest in developing new expression systems for the production of therapeutic proteins. To that end, plants have emerged in the past decade as a suitable alternative to the current production systems, and today their potential for production of high quality, much safer and biologically active complex recombinant pharmaceutical proteins is largely documented. The chapters in this volume, contributed by leaders in the field, sum up the state— the-art methods for using a variety of different plants as expression hosts for phar- ceutical proteins. Several production platforms are presented, ranging from seed- and leaf-based production in stable transgenic plant lines, to plant cell bioreactors, to viral or Agrobacterium-mediated transient expr ession systems. Currently, antibodies and their derived fragments represent the largest and most important group of biote- nological products in clinical trials. This explains why the potential of most prod- tion platforms is illustrated here principally for antibodies or antibody fragments with acknowledged potential for immunotherapy in humans. In addition, a comparison of different plant expression systems is presented using aprotinin, a commercial phar- ceutical protein, as a test system. Although multiple books and monographs have been recently published on mol- ular pharming, there is a noticeable dearth of bench step-by-step prools that can be used quickly and easily by beginners entering this new field.
109.99 In Stock
Recombinant Proteins From Plants: Methods and Protocols

Recombinant Proteins From Plants: Methods and Protocols

Recombinant Proteins From Plants: Methods and Protocols

Recombinant Proteins From Plants: Methods and Protocols

Hardcover(2009)

$109.99 
  • SHIP THIS ITEM
    In stock. Ships in 1-2 days.
  • PICK UP IN STORE

    Your local store may have stock of this item.

Related collections and offers


Overview

Altogether, the biochemical, technical and economic limitations on existing proka- otic and eukaryotic expression systems and the growing clinical demand for complex therapeutic proteins have created substantial interest in developing new expression systems for the production of therapeutic proteins. To that end, plants have emerged in the past decade as a suitable alternative to the current production systems, and today their potential for production of high quality, much safer and biologically active complex recombinant pharmaceutical proteins is largely documented. The chapters in this volume, contributed by leaders in the field, sum up the state— the-art methods for using a variety of different plants as expression hosts for phar- ceutical proteins. Several production platforms are presented, ranging from seed- and leaf-based production in stable transgenic plant lines, to plant cell bioreactors, to viral or Agrobacterium-mediated transient expr ession systems. Currently, antibodies and their derived fragments represent the largest and most important group of biote- nological products in clinical trials. This explains why the potential of most prod- tion platforms is illustrated here principally for antibodies or antibody fragments with acknowledged potential for immunotherapy in humans. In addition, a comparison of different plant expression systems is presented using aprotinin, a commercial phar- ceutical protein, as a test system. Although multiple books and monographs have been recently published on mol- ular pharming, there is a noticeable dearth of bench step-by-step prools that can be used quickly and easily by beginners entering this new field.

Product Details

ISBN-13: 9781588299789
Publisher: Springer-Verlag New York, LLC
Publication date: 11/26/2008
Series: Methods in Molecular Biology , #483
Edition description: 2009
Pages: 358
Product dimensions: 7.60(w) x 10.10(h) x 0.90(d)

Table of Contents

1. From Neanderthal to Nanobiotech: from plant potions to pharming with plant factories Christophe Sourrouille, Brian Marshall, David Liénard and Loïc Faye 2. Cowpea Mosaic Virus-based systems for the expression of antigens and antibodies in plants. Frank Sainsbury, Li Liu and George P. Lomonossoff 3. Transient expression of antibodies in plants using syringe agroinfiltration Marc-André D’Aoust, Pierre-Olivier Lavoie, Julie Belles-Isles, Nicole Bechtold, Michèle Martel and Louis-P. Vézina 4. Rapid system for evaluating bioproduction capacity of complex pharmaceutical proteins in plants Giuliana Medrano, Michael J. Reidy, Jianyun Liu, Jorge Ayala, Maureen C. Dolan and Carole L. Cramer 5. Production and localization of recombinant pharmaceuticals in transgenic seeds Thomas Rademacher, Elsa Arcalis and Eva Stoger 6. Production of antibody fragments in Arabidopsis seeds Bart Van Droogenbroeck, Kirsten De Wilde and Ann Depicker 7. Production of plantibodies in Nicotiana plants Marta Ayala, Jorge Gavilondo, Meilyn Rodríguez, Alejandro Fuentes, Gil Enríquez, Lincidio Pérez, José Cremata, and Merardo Pujol. 8. Physcomitrella patens: a non-vascular plant for recombinant protein production David Lienard and Fabien Nogue 9. Production of recombinant proteins in suspension-cultured plant cells Carole Plasson, Rémy Michel, David Lienard, Claude Saint-Jore-Dupas, Christophe Sourrouille, Ghislaine Grenier de March and Véronique Gomord 10. Chloroplast-derived vaccine antigens and biopharmaceuticals: Prools for expression, purification or oral delivery and functional evaluation N. Dolendro Singh, Yi Ding and Henry Daniell 11. Protein body induction: a new tool to produce and recover recombinant proteins inplants Margarita Torrent, Imma Llop and M.Dolors Ludevid 12. A case study for plant-made pharmaceuticals comparing different plant expression and production systems Guy Vancanneyt, Manuel Dubald, Werner Schröder, Jörg Peters and Johan Botterman 13. Glycosylation of antibody therapeutics: optimisation for purpose Roy Jefferis 14. N-Glycosylation of Plant Recombinant Pharmaceuticals Muriel Bardor, Gleysin Cabrera, Johannes Stadlmann, Patrice Lerouge, José A. Cremata, Véronique Gomord and Anne-Catherine Fitchette 15. Companion protease inhibitors to protect recombinant proteins in transgenic plant extracts Meriem Benchabane, Daniel Rivard, Cécile Girard, and Dominique Michaud 16. Strategies for improving vaccine antigens expression in transgenic plants. Fusion to carrier sequences Jose M. Escribano and Daniel M. Perez-Filgueira 17. Immunomodulation of plant function by in vitro selected single-chain Fv intrabodies Manfred Gahrtz and Udo Conrad 18. On-chip detection of low-molecular-weight recombinant proteins in plant crude extracts by SELDI-TOF MS Amine M. Badri, Karine Coenen, Louis-Philippe Vaillancourt, Charles Goulet, and Dominique Michaud 19. Assessing the Risk of Undesirable Immunogenicity/Allergenicity of Plant-Derived Therapeutic Proteins Paul D. Chamberlain 20. Biosafety, Risk Assessment and Regulation of Plant-made Pharmaceuticals Penelope A.C.Sparrow and Richard M.Twyman
From the B&N Reads Blog

Customer Reviews